Chemoinformaics analysis of (+)-Gallocatechin
| Molecular Weight | 306.27 | nRot | 1 |
| Heavy Atom Molecular Weight | 292.158 | nRig | 17 |
| Exact Molecular Weight | 306.074 | nRing | 3 |
| Solubility: LogS | -2.596 | nHRing | 1 |
| Solubility: LogP | 0.9 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 39.9991 |
| nHD | 6 | BPOL | 15.7809 |
| QED | 0.437 |
| Synth | 3.521 |
| Natural Product Likeliness | 2.272 |
| NR-PPAR-gamma | 0.596 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.02 |
| HIA | 0.096 |
| CACO-2 | -6.362 |
| MDCK | 0.00000413 |
| BBB | 0.022 |
| PPB | 0.886131 |
| VDSS | 0.649 |
| FU | 0.138978 |
| CYP1A2-inh | 0.142 |
| CYP1A2-sub | 0.121 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.05 |
| CYP2c9-inh | 0.221 |
| CYP2c9-sub | 0.466 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.22 |
| CYP3a4-inh | 0.179 |
| CYP3a4-sub | 0.125 |
| CL | 16.047 |
| T12 | 0.913 |
| hERG | 0.103 |
| Ames | 0.496 |
| ROA | 0.142 |
| SkinSen | 0.964 |
| Carcinogencity | 0.053 |
| EI | 0.909 |
| Respiratory | 0.086 |
| NR-Aromatase | 0.476 |
| Antiviral | Yes |
| Prediction | 0.836236 |